Pfizer Subsidiary Warned for Drug Quality Concerns

Drug Industry Daily
A A
The FDA issued a warning to Pfizer subsidiary Hospira Healthcare India for contamination risks, out-of-specification batches and other violations observed at its Chennai, Tamil Nadu facility.

To View This Article:

Login

Subscribe To Drug Industry Daily